- Home
- Publications
- Publication Search
- Publication Details
Title
Interference between copper transport systems and platinum drugs
Authors
Keywords
Cisplatin, Cancer, Copper transporters, Copper homeostasis, Platinum trafficking, Cisplatin resistance, Sensitization therapy, Pt-interference with copper metabolism, CTR1, ATP7A, ATP7B, ATOX1
Journal
SEMINARS IN CANCER BIOLOGY
Volume 76, Issue -, Pages 173-188
Publisher
Elsevier BV
Online
2021-05-29
DOI
10.1016/j.semcancer.2021.05.023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer
- (2020) Arundhati Jana et al. PLoS One
- Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration
- (2020) Stéphanie Blockhuys et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
- (2020) Marta Mariniello et al. Cancers
- Role of Nucleotide Excision Repair in Cisplatin Resistance
- (2020) Mingrui Duan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
- (2020) Pierre Lelièvre et al. Cancers
- Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells
- (2019) Silvia Baldari et al. Cancers
- Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs
- (2019) Alessia Lasorsa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs
- (2019) Raffaella Petruzzelli et al. Cells
- Differential Reactivity of Metal Binding Domains of Copper ATPases towards Cisplatin and Colocalization of Copper and Platinum
- (2018) Tiantian Fang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Platinum drugs, copper transporters and copper chelators
- (2018) Fabio Arnesano et al. COORDINATION CHEMISTRY REVIEWS
- Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1
- (2018) Yao Tian et al. Metallomics
- Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
- (2017) Samuel G. Awuah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Cisplatin binding to proteins: A structural perspective
- (2016) Luigi Messori et al. COORDINATION CHEMISTRY REVIEWS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
- (2016) Cristine L. Chisholm et al. Oncotarget
- Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
- (2015) Szu-Jung Chen et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacological activity of metal binding agents that alter copper bioavailability
- (2015) Marian E. Helsel et al. DALTON TRANSACTIONS
- Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
- (2015) Helena Öhrvik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy
- (2015) Helena Öhrvik et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Curcumin and cancer: barriers to obtaining a health claim
- (2015) J. G. Devassy et al. NUTRITION REVIEWS
- Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro
- (2015) Dana Kahra et al. PROTEIN AND PEPTIDE LETTERS
- HMGB1 bound to cisplatin–DNA adducts undergoes extensive acetylation and phosphorylation in vivo
- (2015) Yafeng He et al. Chemical Science
- Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function
- (2015) Gin-Fu Chen et al. Scientific Reports
- Biochemical characterization of P-type copper ATPases
- (2014) Giuseppe Inesi et al. BIOCHEMICAL JOURNAL
- Structural Biology of Cisplatin Complexes with Cellular Targets: The Adduct with Human Copper Chaperone Atox1 in Aqueous Solution
- (2014) Vania Calandrini et al. CHEMISTRY-A EUROPEAN JOURNAL
- Platination of the copper transporter ATP7A involved in anticancer drug resistance
- (2014) Vania Calandrini et al. DALTON TRANSACTIONS
- Cisplatin handover between copper transporters: the effect of reducing agents
- (2014) Angela Galliani et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells
- (2013) Michael A. Cater et al. ACS Chemical Biology
- Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
- (2013) Francesco Tadini-Buoninsegni et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification
- (2013) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1
- (2013) Zhaoyong Xi et al. CHEMICAL COMMUNICATIONS
- An Updated View of Cisplatin Transport
- (2013) Fabio Arnesano et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Determinants for Simultaneous Binding of Copper and Platinum to Human Chaperone Atox1: Hitchhiking not Hijacking
- (2013) Maria E. Palm-Espling et al. PLoS One
- Bioavailable copper modulates oxidative phosphorylation and growth of tumors
- (2013) S. Ishida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain
- (2013) H. Ohrvik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Better Platinum-Based Anticancer Drug Yet to Come?
- (2012) Ulrike Olszewski et al. Anti-Cancer Agents in Medicinal Chemistry
- Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling
- (2012) Cheng-Yu Tsai et al. BIOCHEMICAL PHARMACOLOGY
- Reaction of platinum anticancer drugs and drug derivatives with a copper transporting protein, Atox1
- (2012) Maria E. Palm-Espling et al. BIOCHEMICAL PHARMACOLOGY
- Binding Interaction of HMGB4 with Cisplatin-Modified DNA
- (2012) Semi Park et al. BIOCHEMISTRY
- Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach
- (2012) Trung Hai Nguyen et al. Journal of Chemical Theory and Computation
- Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells
- (2012) Ganna V. Kalayda et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
- (2012) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC)
- (2012) Zhuang-hua Li et al. Journal of Translational Medicine
- Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
- (2012) Xiaojing Xu et al. LUNG CANCER
- A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling
- (2012) M. L. Turski et al. MOLECULAR AND CELLULAR BIOLOGY
- Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila
- (2011) Haiqing Hua et al. BIOMETALS
- Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy
- (2011) Yoo-Young Lee et al. GYNECOLOGIC ONCOLOGY
- Probing the Interaction of Cisplatin with the Human Copper Chaperone Atox1 by Solution and In-Cell NMR Spectroscopy
- (2011) Fabio Arnesano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro
- (2011) M. E. Palm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Copper Metallochaperones
- (2010) Nigel J. Robinson et al. Annual Review of Biochemistry
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin
- (2009) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
- (2009) B. G. Blair et al. CLINICAL CANCER RESEARCH
- Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
- (2009) Di Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Cisplatin Overdose
- (2009) Roger Y. Tsang et al. DRUG SAFETY
- Human copper transporters: mechanism, role in human diseases and therapeutic potential
- (2009) Arnab Gupta et al. Future Medicinal Chemistry
- New-generation platinum agents for solid tumors
- (2009) Neel Shah et al. Future Oncology
- Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
- (2009) Zhengyi Wu et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Crystal Structures of Cisplatin Bound to a Human Copper Chaperone
- (2009) Amie K. Boal et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1
- (2009) Sarah E. Crider et al. Metallomics
- Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
- (2009) H. M. Alvarez et al. SCIENCE
- Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine
- (2009) George J. Brewer et al. Translational Research
- The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters
- (2009) Olena Kis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- Novel mechanism for regulation of extracellular SOD transcription and activity by copper: Role of antioxidant-1
- (2008) S ITOH et al. FREE RADICAL BIOLOGY AND MEDICINE
- Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation
- (2008) Shinichi Itoh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction of cisplatin and analogues with a Met-rich protein site
- (2008) Chak Ming Sze et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Effects of the loss of Atox1 on the cellular pharmacology of cisplatin
- (2008) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
- Unique Properties of DNA Interstrand Cross-Links of Antitumor Oxaliplatin and the Effect of Chirality of the Carrier Ligand
- (2007) Jana Kasparkova et al. CHEMISTRY-A EUROPEAN JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started